Katerina Gkirtzimanaki
Katerina Gkirtzimanaki
Post-Doc, IMBB-FORTH
Verified email at imbb.forth.gr - Homepage
Title
Cited by
Cited by
Year
CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium
R Sadej, H Romanska, G Baldwin, K Gkirtzimanaki, V Novitskaya, ...
Molecular Cancer Research 7 (6), 787-798, 2009
1162009
Suppression of integrin 􊕇 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells
K Mitchell, KB Svenson, WM Longmate, K Gkirtzimanaki, R Sadej, ...
Cancer research 70 (15), 6359-6367, 2010
1102010
IFN impairs autophagic degradation of mtDNA promoting autoreactivity of SLE monocytes in a STING-dependent fashion
K Gkirtzimanaki, E Kabrani, D Nikoleri, A Polyzos, A Blanas, ...
Cell reports 25 (4), 921-933. e5, 2018
452018
TPL2 kinase is a suppressor of lung carcinogenesis
K Gkirtzimanaki, KK Gkouskou, U Oleksiewicz, G Nikolaidis, D Vyrla, ...
Proceedings of the National Academy of Sciences 110 (16), E1470-E1479, 2013
452013
Tissue-infiltrating macrophages mediate an exosome-based metabolic reprogramming upon DNA damage
E Goulielmaki, A Ioannidou, M Tsekrekou, K Stratigi, IK Poutakidou, ...
Nature communications 11 (1), 1-18, 2020
252020
Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand
L Liljenfeldt, K Gkirtzimanaki, D Vyrla, E Svensson, ASI Loskog, ...
Cancer Immunology, Immunotherapy 63 (3), 273-282, 2014
232014
O003 Characterising the role of net-derived IL-33 in SLE pathogenesis
S Georgakis, G Papadaki, I Gergianaki, C Adamichou, S Polia, ...
Annals of the Rheumatic Diseases 77 (Suppl 1), A2-A2, 2018
12018
NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN production in SLE patients
S Georgakis, K Gkirtzimanaki, G Papadaki, H Gakiopoulou, E Drakos, ...
JCI insight, 2021
2021
P107 Interferon-induced metabolic perturbations shape the inflammatory status of human monocytes: implications for innovative therapeutic engineering in SLE autoimmunity
C Stathopoulou, V Ntassis, A Banos, K Gkirtzimanaki, A Myridakis, ...
Lupus Science & Medicine 7 (Suppl 1), 2020
2020
ERCC1-XPF Interacts with Topoisomerase II to Facilitate the Repair of Activity-induced DNA Breaks
G Chatzinikolaou, K Stratigi, K Agathangelou, M Tsekrekou, ...
bioRxiv, 2020
2020
AB0048 CHARACTERIZING THE ROLE OF NET-DERIVED IL-33 IN SLE PATHOGENESIS
G Spiros, G Papadaki, E Drakos, C Giakopoulou, ML Eloranta, ...
Annals of the Rheumatic Diseases 78 (Suppl 2), 1490-1490, 2019
2019
08.31 Unravelling the role of il33/st2l axis on sustained ifn-a production in systemic lupus erythematosus
S Georgakis, G Papadaki, I Gergianaki, P Sidiropoulos, P Verginis, ...
Annals of the Rheumatic Diseases 76 (Suppl 1), A88-A88, 2017
2017
IFN (ALPHA)-MEDIATED DEREGULATION OF MITOCHONDRIAL DNA CLEARANCE PROMOTES THE AUTOREACTIVE PHENOTYPE OF PERIPHERAL BLOOD MONOCYTES IN HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS
K Gkirtzimanaki, E Kabrani, A Mplanas, P Sidiropoulos, G Bertsias, ...
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 34 (4), S54-S54, 2016
2016
A1. 23 IFN mediated deregulation of mitochondrial DNA clearance as an inciting event for the development of SLE autoimmunity
K Gkirtzimanaki, E Kabrani, A Mplanas, P Sidiropoulos, G Bertsias, ...
Annals of the Rheumatic Diseases 75 (Suppl 1), A10-A10, 2016
2016
Deregulated, IFN driven autophagy shapes the phenotype of autoreactive SLE monocytes
Gkirtzimanaki K, Kabrani E, Mplanas A
Annals of Rheumatic Diseases, 2015
2015
AdCD40L gene therapy enhances the efficacy of chemotherapy in experimental bladder cancer
L Liljenfeldt, K Gkirtzimanaki, A Loskog, A Eliopoulos
HUMAN GENE THERAPY 20 (11), 1474-1474, 2009
2009
G., Lalani el-N., Berditchevski F.(2009) Mol
R Sadej, H Romanska, G Baldwin, K Gkirtzimanaki, V Novitskaya, ...
Cancer Res 7, 787-798, 0
The system can't perform the operation now. Try again later.
Articles 1–17